SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

There is a lot of free information.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 46
Posts 6,123
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
TroyGould Advises Haitong International in its $190 Million Acquisition of Obagi Skincare Products Business "PR Newswire (US)" - 11/16/2017 1:00:00 PM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (Canada)" - 11/15/2017 8:00:00 AM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (US)" - 11/15/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2017 5:02:27 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (Canada)" - 11/14/2017 4:10:00 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (US)" - 11/14/2017 4:10:00 PM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (Canada)" - 11/14/2017 9:00:00 AM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (US)" - 11/14/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 7:47:10 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (Canada)" - 11/13/2017 7:35:00 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (US)" - 11/13/2017 7:35:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (Canada)" - 11/10/2017 7:00:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (US)" - 11/10/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/9/2017 7:54:54 AM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (Canada)" - 11/8/2017 6:02:00 PM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (US)" - 11/8/2017 6:02:00 PM
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery "GlobeNewswire Inc." - 11/8/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2017 5:29:18 PM
Valeant Shares Rise As It Makes Progress on Debt -- Market Talk "Dow Jones News" - 11/7/2017 8:36:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 7:05:32 AM
Valeant Announces Third-Quarter 2017 Results "PR Newswire (Canada)" - 11/7/2017 7:00:00 AM
Valeant Announces Third-Quarter 2017 Results "PR Newswire (US)" - 11/7/2017 7:00:00 AM
Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals "PR Newswire (Canada)" - 11/6/2017 7:00:00 AM
Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals "PR Newswire (US)" - 11/6/2017 7:00:00 AM
Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (latanoprostene Bunod Ophthalmic Solution), 0.024% "PR Newswire (US)" - 11/2/2017 4:26:00 PM
JLS   Friday, 11/10/17 10:01:40 AM
Re: JohnCM post# 3879
Post # of 3961 
There is a lot of free information.

Avoid any place that wants an up-front fee.

Do a search then pick one by a reputable site. If it doesn't work for you by making it seem too complicated, or use a lot of jargon (greeks), or try to hook you into buying something, try another.

For instance, I just did a search and I think this should work:

http://www.option-trading-guide.com/

If you want help, ask questions.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist